Meditation for White Coat Hypertensio

Not Applicable

Recruiting

• Conditions: White Coat Hypertension; Cardiovascular - Other cardiovascular diseases; Public Health - Health service research

• Registration Number: ACTRN12623000703606
• Lead Sponsor: Southern Cross University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-30
• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Generally healthy
- 25 and 65 years of age
- confirmed white coat hypertension within the past 6 months
- BMI between 18.5 and 35 kg/m2; - Generally healthy
- 25 and 65 years of age
- confirmed white coat hypertension within the past 6 months
- BMI between 18.5 and 35 kg/m2

Exclusion Criteria

- Pregnancy or breastfeeding
- Current use of blood pressure lowering medication, including natural products
- Use of psychotropics, with the exception of stable medication for at least 6 months
- Smoking, high-risk alcohol consumption, or use of illicit drugs
- Conditions that prohibit the wearing of a blood pressure monitor such as skin conditions (e.g., eczema, psoriasis), arm injuries or surgeries (incl. recent vaccinations), peripheral artery disease, or neurological conditions (e.g., tremor, paresis, movement disorders), or thoracic outlet syndrome; - Pregnancy or breastfeeding
- Current use of blood pressure lowering medication, including natural products
- Use of psychotropics, with the exception of stable medication for at least 6 months
- Smoking, high-risk alcohol consumption, or use of illicit drugs
- Conditions that prohibit the wearing of a blood pressure monitor such as skin conditions (e.g., eczema, psoriasis), arm injuries or surgeries (incl. recent vaccinations), peripheral artery disease, or neurological conditions (e.g., tremor, paresis, movement disorders), or thoracic outlet syndrome

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood pressure measured using automated sphygmomanometer[ immediately before and after each intervention];blood pressure measured using automated sphygmomanometer[ immediately before and after each intervention]

Secondary Outcome Measures

Name	Time	Method
Heart rate in beats per minute using automated sphygmomanometer[ immediately before and after each intervention];Respiratory rate in breaths per minute via manual count by clinician[ immediately before and after each intervention];Stress via 100mm visual analogue scale[ immediately before and after each intervention];Nervousness via 100mm visual analogue scale[ immediately before and after each intervention];Tension via 100mm visual analogue scale[ immediately before and after each intervention];Heart rate in beats per minute using automated sphygmomanometer[ immediately before and after each intervention];Respiratory rate in breaths per minute via manual count by clinician[ immediately before and after each intervention];Stress via 100mm visual analogue scale[ immediately before and after each intervention];Nervousness via 100mm visual analogue scale[ immediately before and after each intervention];Tension via 100mm visual analogue scale[ immediately before and after each intervention]